$FURX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Furiex Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Furiex Pharmaceuticals, Inc.. Get notifications about new insider transactions in Furiex Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Option Exercise | D | 17.80 | 10,368 | 184,550 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Option Exercise | D | 13.16 | 26,219 | 345,042 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Option Exercise | D | 9.11 | 22,763 | 207,371 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Sell | D | 0.00 | 24,318 | 0 | 0 | 24.3 K to 0 (-100.00 %) |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Option Exercise | D | 13.16 | 37,944 | 499,343 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Option Exercise | D | 15.00 | 26,000 | 390,000 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Sell | D | 0.00 | 22,523 | 0 | 0 | 22.5 K to 0 (-100.00 %) |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Option Exercise | D | 13.16 | 98,813 | 1,300,379 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Option Exercise | D | 9.11 | 65,876 | 600,130 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Sell | D | 0.00 | 140 | 0 | 0 | 140 to 0 (-100.00 %) |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Sell | D | 0.00 | 41,666 | 0 | 0 | 41.7 K to 0 (-100.00 %) |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Sell | D | 0.00 | 132,689 | 0 | 0 | 132.7 K to 0 (-100.00 %) |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Sell | D | 0.00 | 2,673,522 | 0 | 0 | 2.7 M to 0 (-100.00 %) |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | DIXON WENDY L | Director | Option Exercise | D | 18.22 | 17,500 | 318,850 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | DIXON WENDY L | Director | Option Exercise | D | 13.45 | 8,825 | 118,696 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | DIXON WENDY L | Director | Option Exercise | D | 13.94 | 8,675 | 120,930 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | DIXON WENDY L | Director | Option Exercise | D | 9.11 | 17,570 | 160,063 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | DIXON WENDY L | Director | Sell | D | 0.00 | 7,160 | 0 | 0 | 7.2 K to 0 (-100.00 %) |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Option Exercise | D | 18.22 | 17,500 | 318,850 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Option Exercise | D | 13.45 | 8,825 | 118,696 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Option Exercise | D | 13.94 | 8,675 | 120,930 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Option Exercise | D | 9.11 | 5,470 | 49,832 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Sell | D | 0.00 | 8,447 | 0 | 0 | 8.4 K to 0 (-100.00 %) |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Option Exercise | D | 17.80 | 6,912 | 123,034 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Option Exercise | D | 13.16 | 21,970 | 289,125 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Option Exercise | D | 15.00 | 27,000 | 405,000 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Option Exercise | D | 9.11 | 83,000 | 756,130 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Sell | D | 0.00 | 24,600 | 0 | 0 | 24.6 K to 0 (-100.00 %) |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Patel Sailash | Chief Financial Off ... | Option Exercise | D | 17.80 | 8,294 | 147,633 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Patel Sailash | Chief Financial Off ... | Option Exercise | D | 13.16 | 29,644 | 390,115 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Patel Sailash | Chief Financial Off ... | Option Exercise | D | 15.00 | 20,000 | 300,000 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Patel Sailash | Chief Financial Off ... | Option Exercise | D | 9.11 | 26,360 | 240,140 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Patel Sailash | Chief Financial Off ... | Sell | D | 0.00 | 26,444 | 0 | 0 | 26.4 K to 0 (-100.00 %) |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Kaldor Stephen W | Director | Option Exercise | D | 18.22 | 17,500 | 318,850 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Kaldor Stephen W | Director | Option Exercise | D | 13.45 | 8,825 | 118,696 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Kaldor Stephen W | Director | Option Exercise | D | 13.94 | 5,012 | 69,867 | 0 | |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Kaldor Stephen W | Director | Sell | D | 0.00 | 7,160 | 0 | 0 | 7.2 K to 0 (-100.00 %) |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | DAVIS STEPHEN | Director | Sell | D | 0.00 | 9,308 | 0 | 0 | 9.3 K to 0 (-100.00 %) |
Jul 07 2014 | FURX | Furiex Pharmaceuti ... | Forest Laboratories, LLC | 10% Owner | Buy | P | 95.00 | 11,169,066 | 1,061,061,270 | 0 | -11,169,066 to 0 (-100.00 %) |
Jun 26 2014 | FURX | Furiex Pharmaceuti ... | Patel Sailash | Chief Financial Off ... | Option Exercise | M | 9.11 | 32,928 | 299,974 | 26,360 | |
Jun 26 2014 | FURX | Furiex Pharmaceuti ... | Patel Sailash | Chief Financial Off ... | Sell | S | 104.00 | 32,928 | 3,424,512 | 26,444 | 59.4 K to 26.4 K (-55.46 %) |
Jun 26 2014 | FURX | Furiex Pharmaceuti ... | Patel Sailash | Chief Financial Off ... | Buy | M | 9.11 | 32,928 | 299,974 | 59,372 | 26.4 K to 59.4 K (+124.52 %) |
Jun 26 2014 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Option Exercise | M | 17.80 | 10,368 | 184,550 | 0 | |
Jun 26 2014 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Sell | S | 104.12 | 10,368 | 1,079,516 | 22,523 | 32.9 K to 22.5 K (-31.52 %) |
Jun 26 2014 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Buy | M | 17.80 | 10,368 | 184,550 | 32,891 | 22.5 K to 32.9 K (+46.03 %) |
Jun 20 2014 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Option Exercise | M | 9.11 | 45,691 | 416,245 | 0 | |
Jun 20 2014 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Sell | S | 104.11 | 45,691 | 4,756,890 | 22,523 | 68.2 K to 22.5 K (-66.98 %) |
Jun 20 2014 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Buy | M | 9.11 | 45,691 | 416,245 | 68,214 | 22.5 K to 68.2 K (+202.86 %) |
Jun 18 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Option Exercise | M | 13.16 | 8,008 | 105,385 | 26,219 | |
Jun 18 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Option Exercise | M | 13.16 | 3,717 | 48,916 | 34,227 | |
Jun 18 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Option Exercise | M | 15.00 | 26,000 | 390,000 | 0 | |
Jun 18 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Option Exercise | M | 9.11 | 32,928 | 299,974 | 22,763 | |
Jun 18 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Sell | S | 105.00 | 8,008 | 840,840 | 24,318 | 32.3 K to 24.3 K (-24.77 %) |
Jun 18 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Buy | M | 13.16 | 8,008 | 105,385 | 32,326 | 24.3 K to 32.3 K (+32.93 %) |
Jun 18 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Sell | S | 105.05 | 3,717 | 390,471 | 24,318 | 28 K to 24.3 K (-13.26 %) |
Jun 18 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Buy | M | 13.16 | 3,717 | 48,916 | 28,035 | 24.3 K to 28 K (+15.28 %) |
Jun 18 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Sell | S | 105.01 | 26,000 | 2,730,260 | 24,318 | 50.3 K to 24.3 K (-51.67 %) |
Jun 18 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Buy | M | 15.00 | 26,000 | 390,000 | 50,318 | 24.3 K to 50.3 K (+106.92 %) |
Jun 18 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Sell | S | 105.00 | 32,928 | 3,457,440 | 24,318 | 57.2 K to 24.3 K (-57.52 %) |
Jun 18 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Buy | M | 9.11 | 32,928 | 299,974 | 57,246 | 24.3 K to 57.2 K (+135.41 %) |
Jun 18 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Sell | S | 105.00 | 3,804 | 399,420 | 24,318 | 28.1 K to 24.3 K (-13.53 %) |
Jun 17 2014 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Sell | S | 104.25 | 3,228 | 336,519 | 22,523 | 25.8 K to 22.5 K (-12.54 %) |
Jun 12 2014 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Sell | S | 104.63 | 2,872 | 300,497 | 25,751 | 28.6 K to 25.8 K (-10.03 %) |
Jun 12 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Sell | S | 104.58 | 1,746 | 182,597 | 28,122 | 29.9 K to 28.1 K (-5.85 %) |
Jun 12 2014 | FURX | Furiex Pharmaceuti ... | Patel Sailash | Chief Financial Off ... | Sell | S | 104.68 | 1,504 | 157,439 | 26,444 | 27.9 K to 26.4 K (-5.38 %) |
Mar 04 2014 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Grant | A | 0.00 | 12,000 | 0 | 29,868 | 17.9 K to 29.9 K (+67.16 %) |
Mar 04 2014 | FURX | Furiex Pharmaceuti ... | Patel Sailash | Chief Financial Off ... | Grant | A | 0.00 | 12,000 | 0 | 27,948 | 15.9 K to 27.9 K (+75.24 %) |
Mar 04 2014 | FURX | Furiex Pharmaceuti ... | Kaldor Stephen W | Director | Grant | A | 0.00 | 3,580 | 0 | 7,160 | 3.6 K to 7.2 K (+100.00 %) |
Mar 04 2014 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Grant | A | 0.00 | 13,500 | 0 | 28,623 | 15.1 K to 28.6 K (+89.27 %) |
Mar 04 2014 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Grant | A | 0.00 | 3,580 | 0 | 8,447 | 4.9 K to 8.4 K (+73.56 %) |
Mar 04 2014 | FURX | Furiex Pharmaceuti ... | DIXON WENDY L | Director | Grant | A | 0.00 | 3,580 | 0 | 7,160 | 3.6 K to 7.2 K (+100.00 %) |
Mar 04 2014 | FURX | Furiex Pharmaceuti ... | DAVIS STEPHEN | Director | Grant | A | 0.00 | 3,580 | 0 | 9,308 | 5.7 K to 9.3 K (+62.50 %) |
Feb 06 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Option Exercise | M | 17.80 | 3,456 | 61,517 | 6,912 | |
Feb 06 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Option Exercise | M | 13.16 | 43,939 | 578,237 | 21,970 | |
Feb 06 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Option Exercise | M | 15.00 | 19,000 | 285,000 | 27,000 | |
Feb 06 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Option Exercise | M | 9.11 | 21,718 | 197,851 | 83,000 | |
Feb 06 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Option Exercise | M | 9.11 | 27,000 | 245,970 | 104,718 | |
Feb 06 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Sell | S | 118.25 | 21,718 | 2,568,154 | 24,600 | 46.3 K to 24.6 K (-46.89 %) |
Feb 06 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Sell | S | 114.60 | 93,395 | 10,703,067 | 46,318 | 139.7 K to 46.3 K (-66.85 %) |
Feb 06 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Buy | M | 17.80 | 3,456 | 61,517 | 139,713 | 136.3 K to 139.7 K (+2.54 %) |
Feb 06 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Buy | M | 13.16 | 43,939 | 578,237 | 136,257 | 92.3 K to 136.3 K (+47.60 %) |
Feb 06 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Buy | M | 15.00 | 19,000 | 285,000 | 92,318 | 73.3 K to 92.3 K (+25.91 %) |
Feb 06 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Buy | M | 9.11 | 21,718 | 197,851 | 73,318 | 51.6 K to 73.3 K (+42.09 %) |
Feb 06 2014 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Buy | M | 9.11 | 27,000 | 245,970 | 51,600 | 24.6 K to 51.6 K (+109.76 %) |
Nov 19 2013 | FURX | Furiex Pharmaceuti ... | Patel Sailash | Chief Financial Off ... | Grant | A | 0.00 | 1,000 | 0 | 15,948 | 14.9 K to 15.9 K (+6.69 %) |
Sep 12 2013 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Option Exercise | M | 9.11 | 30,000 | 273,300 | 45,691 | |
Sep 12 2013 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Sell | S | 40.89 | 30,000 | 1,226,700 | 15,123 | 45.1 K to 15.1 K (-66.48 %) |
Sep 12 2013 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Buy | M | 9.11 | 30,000 | 273,300 | 45,123 | 15.1 K to 45.1 K (+198.37 %) |
Aug 13 2013 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Option Exercise | M | 9.11 | 7,500 | 68,325 | 5,470 | |
Aug 13 2013 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Sell | S | 39.74 | 7,500 | 298,050 | 3,580 | 11.1 K to 3.6 K (-67.69 %) |
Aug 13 2013 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Buy | M | 9.11 | 7,500 | 68,325 | 11,080 | 3.6 K to 11.1 K (+209.50 %) |
Jul 23 2013 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Option Exercise | M | 9.11 | 20,000 | 182,200 | 55,691 | |
Jul 23 2013 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Sell | S | 40.00 | 10,581 | 423,240 | 17,868 | 28.4 K to 17.9 K (-37.19 %) |
Jul 23 2013 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Payment of Exercise | F | 40.00 | 9,419 | 376,760 | 28,449 | 37.9 K to 28.4 K (-24.87 %) |
Jul 23 2013 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Buy | M | 9.11 | 20,000 | 182,200 | 37,868 | 17.9 K to 37.9 K (+111.93 %) |
Jul 02 2013 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Gift | G | 0.00 | 15 | 0 | 3,580 | 3.6 K to 3.6 K (-0.42 %) |
Jul 02 2013 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Gift | G | 0.00 | 2,913 | 0 | 3,595 | 6.5 K to 3.6 K (-44.76 %) |
Jul 02 2013 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Sell | S | 34.03 | 385 | 13,102 | 6,508 | 6.9 K to 6.5 K (-5.59 %) |
Jul 02 2013 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Grant | A | 0.00 | 7,161 | 0 | 2,673,522 | 2.7 M to 2.7 M (+0.27 %) |
Jun 26 2013 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Option Exercise | M | 9.11 | 1,000 | 9,110 | 12,970 | |
Jun 26 2013 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Option Exercise | M | 9.11 | 3,600 | 32,796 | 13,970 | |
Jun 26 2013 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Payment of Exercise | F | 33.30 | 400 | 13,319 | 6,893 | 7.3 K to 6.9 K (-5.48 %) |
Jun 26 2013 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Buy | M | 9.11 | 1,000 | 9,110 | 7,293 | 6.3 K to 7.3 K (+15.89 %) |
Jun 26 2013 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Payment of Exercise | F | 33.12 | 887 | 29,375 | 6,293 | 7.2 K to 6.3 K (-12.35 %) |
Jun 26 2013 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Buy | M | 9.11 | 3,600 | 32,796 | 7,180 | 3.6 K to 7.2 K (+100.56 %) |
Jun 12 2013 | FURX | Furiex Pharmaceuti ... | Woodworth Marshall H | Chief Financial Off ... | Grant | A | 0.00 | 10,200 | 0 | 16,411 | 6.2 K to 16.4 K (+164.22 %) |
Jun 12 2013 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Grant | A | 0.00 | 12,200 | 0 | 15,123 | 2.9 K to 15.1 K (+417.38 %) |
Jun 12 2013 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Grant | A | 0.00 | 11,100 | 0 | 17,868 | 6.8 K to 17.9 K (+164.01 %) |
May 29 2013 | FURX | Furiex Pharmaceuti ... | DAVIS STEPHEN | Director | Grant | A | 0.00 | 5,728 | 0 | 5,728 | 0 to 5.7 K |
Jun 12 2013 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Grant | A | 0.00 | 17,600 | 0 | 24,600 | 7 K to 24.6 K (+251.43 %) |
May 29 2013 | FURX | Furiex Pharmaceuti ... | Kaldor Stephen W | Director | Grant | A | 0.00 | 3,580 | 0 | 3,580 | 0 to 3.6 K |
May 29 2013 | FURX | Furiex Pharmaceuti ... | DIXON WENDY L | Director | Grant | A | 0.00 | 3,580 | 0 | 3,580 | 0 to 3.6 K |
May 29 2013 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Grant | A | 0.00 | 3,580 | 0 | 3,580 | 0 to 3.6 K |
Mar 13 2013 | FURX | Furiex Pharmaceuti ... | Ruscher Robert P | Director | Option Exercise | M | 9.11 | 17,570 | 160,063 | 0 | |
Mar 13 2013 | FURX | Furiex Pharmaceuti ... | Ruscher Robert P | Director | Option Exercise | M | 13.94 | 8,675 | 120,930 | 0 | |
Mar 13 2013 | FURX | Furiex Pharmaceuti ... | Ruscher Robert P | Director | Option Exercise | M | 13.45 | 8,825 | 118,696 | 0 | |
Mar 13 2013 | FURX | Furiex Pharmaceuti ... | Ruscher Robert P | Director | Sell | S | 40.71 | 4,262 | 173,506 | 7,243 | 11.5 K to 7.2 K (-37.04 %) |
Mar 13 2013 | FURX | Furiex Pharmaceuti ... | Ruscher Robert P | Director | Sell | S | 41.74 | 23,565 | 983,603 | 11,505 | 35.1 K to 11.5 K (-67.19 %) |
Mar 13 2013 | FURX | Furiex Pharmaceuti ... | Ruscher Robert P | Director | Buy | M | 9.11 | 17,570 | 160,063 | 35,070 | 17.5 K to 35.1 K (+100.40 %) |
Mar 13 2013 | FURX | Furiex Pharmaceuti ... | Ruscher Robert P | Director | Buy | M | 13.94 | 8,675 | 120,930 | 17,500 | 8.8 K to 17.5 K (+98.30 %) |
Mar 13 2013 | FURX | Furiex Pharmaceuti ... | Ruscher Robert P | Director | Buy | M | 13.45 | 8,825 | 118,696 | 8,825 | 0 to 8.8 K |
Mar 13 2013 | FURX | Furiex Pharmaceuti ... | Kaldor Stephen W | Director | Option Exercise | M | 13.94 | 8,000 | 111,520 | 5,012 | |
Mar 13 2013 | FURX | Furiex Pharmaceuti ... | Kaldor Stephen W | Director | Sell | S | 40.71 | 973 | 39,611 | 1,648 | 2.6 K to 1.6 K (-37.12 %) |
Mar 13 2013 | FURX | Furiex Pharmaceuti ... | Kaldor Stephen W | Director | Sell | S | 41.74 | 5,379 | 224,519 | 2,621 | 8 K to 2.6 K (-67.24 %) |
Mar 13 2013 | FURX | Furiex Pharmaceuti ... | Kaldor Stephen W | Director | Buy | M | 13.94 | 8,000 | 111,520 | 8,000 | 0 to 8 K |
Aug 16 2012 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Buy | P | 18.68 | 950 | 17,746 | 7,000 | 6.1 K to 7 K (+15.70 %) |
Aug 16 2012 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Buy | P | 18.55 | 50 | 928 | 6,050 | 6 K to 6.1 K (+0.83 %) |
Jun 22 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Option Exercise | M | 9.11 | 65,875 | 600,121 | 65,876 | |
Jun 22 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | M | 9.11 | 65,875 | 600,121 | 132,689 | 66.8 K to 132.7 K (+98.59 %) |
Jun 15 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | P | 19.04 | 34,133 | 649,892 | 2,666,361 | 2.6 M to 2.7 M (+1.30 %) |
Jun 15 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | P | 18.33 | 44,193 | 810,058 | 2,632,228 | 2.6 M to 2.6 M (+1.71 %) |
Jun 04 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | P | 19.72 | 50,319 | 992,291 | 2,588,035 | 2.5 M to 2.6 M (+1.98 %) |
Jun 04 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | P | 20.06 | 70,075 | 1,405,705 | 2,537,716 | 2.5 M to 2.5 M (+2.84 %) |
May 31 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | P | 19.87 | 96,321 | 1,913,898 | 2,467,641 | 2.4 M to 2.5 M (+4.06 %) |
May 31 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | P | 19.96 | 72,431 | 1,445,723 | 2,371,320 | 2.3 M to 2.4 M (+3.15 %) |
May 29 2012 | FURX | Furiex Pharmaceuti ... | Ruscher Robert P | Director | Option Exercise | A | 18.22 | 17,500 | 318,850 | 17,500 | |
May 29 2012 | FURX | Furiex Pharmaceuti ... | Kaldor Stephen W | Director | Option Exercise | A | 18.22 | 17,500 | 318,850 | 17,500 | |
May 29 2012 | FURX | Furiex Pharmaceuti ... | DIXON WENDY L | Director | Option Exercise | A | 18.22 | 17,500 | 318,850 | 17,500 | |
May 29 2012 | FURX | Furiex Pharmaceuti ... | CORR PETER B | Director | Option Exercise | A | 18.22 | 17,500 | 318,850 | 17,500 | |
May 29 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | P | 18.45 | 1,454 | 26,826 | 2,298,889 | 2.3 M to 2.3 M (+0.06 %) |
May 25 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | P | 17.99 | 27,000 | 485,730 | 2,297,435 | 2.3 M to 2.3 M (+1.19 %) |
May 22 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | P | 16.15 | 2,400 | 38,760 | 2,215,435 | 2.2 M to 2.2 M (+0.11 %) |
May 24 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | P | 17.73 | 20,000 | 354,600 | 2,270,435 | 2.3 M to 2.3 M (+0.89 %) |
May 24 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | P | 16.93 | 35,000 | 592,550 | 2,250,435 | 2.2 M to 2.3 M (+1.58 %) |
May 18 2012 | FURX | Furiex Pharmaceuti ... | Almenoff June Sherie | President | Buy | P | 14.80 | 2,000 | 29,600 | 6,000 | 4 K to 6 K (+50.00 %) |
May 21 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | P | 15.28 | 25,000 | 382,000 | 2,213,035 | 2.2 M to 2.2 M (+1.14 %) |
Apr 11 2012 | FURX | Furiex Pharmaceuti ... | Woodworth Marshall H | Chief Financial Off ... | Option Exercise | A | 17.80 | 8,294 | 147,633 | 8,294 | |
Apr 11 2012 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Option Exercise | A | 17.80 | 10,368 | 184,550 | 10,368 | |
Apr 11 2012 | FURX | Furiex Pharmaceuti ... | COVINGTON PAUL S | Senior VP-Clinical ... | Option Exercise | A | 17.80 | 10,368 | 184,550 | 10,368 | |
Mar 15 2012 | FURX | Furiex Pharmaceuti ... | ESHELMAN FREDRIC N | Director | Buy | P | 23.75 | 22,713 | 539,434 | 2,180,933 | 2.2 M to 2.2 M (+1.05 %) |